Our data showed that compared to the control group, SuperPDL1exo could enhance infiltration of CD8+ T cells in tumors; increase the expression of cytotoxic granules such as perforin, granzyme B, and granzyme A; and exert antitumor effects in the MC38 colon cancer model. This evidence concerns the gene CD8A and malignant colon neoplasm.